+ |
MTOR | up-regulates activity
phosphorylation
|
NRBF2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265874 |
Ser113 |
AEDAEGQsPLSQKYS |
Homo sapiens |
U2-OS Cell |
pmid |
sentence |
28059666 |
Human NRBF2 is phosphorylated by MTORC1 at S113 and S120. Upon nutrient starvation or MTORC1 inhibition, NRBF2 phosphorylation is diminished. Phosphorylated NRBF2 preferentially interacts with PIK3C3/PIK3R4. Suppression of NRBF2 phosphorylation by MTORC1 inhibition alters its binding preference from PIK3C3/PIK3R4 to ATG14/BECN1, leading to increased autophagic PtdIns3K complex assembly, as well as enhancement of ULK1 protein complex association. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265875 |
Ser120 |
SPLSQKYsPSTEKCL |
Homo sapiens |
U2-OS Cell |
pmid |
sentence |
28059666 |
Human NRBF2 is phosphorylated by MTORC1 at S113 and S120. Upon nutrient starvation or MTORC1 inhibition, NRBF2 phosphorylation is diminished. Phosphorylated NRBF2 preferentially interacts with PIK3C3/PIK3R4. Suppression of NRBF2 phosphorylation by MTORC1 inhibition alters its binding preference from PIK3C3/PIK3R4 to ATG14/BECN1, leading to increased autophagic PtdIns3K complex assembly, as well as enhancement of ULK1 protein complex association. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
MTOR | up-regulates activity
phosphorylation
|
ELP1 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-275541 |
Ser1174 |
SETSSVVsGSEMSGK |
|
|
pmid |
sentence |
29925953 |
Human ELP1 S1174 phosphorylation was triggered by insulin treatment, as shown by the specific phosphorylated (p)ELP1 (S1174) antibody, and addition of a phosphorylation-mutant variant of the ELP1 protein (ELP1(S1174A)) to ELP1-depleted BRAFV600E melanoma cells failed to rescue cell survival |In line with these findings, mTORC2 activity, but not mTORC1, was required for the insulin-induced phosphorylation of Elp1 S1174 |
|
Publications: |
1 |
+ |
AMPK | up-regulates activity
phosphorylation
|
MTOR |
0.549 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-262535 |
Ser1261 |
PMKKLHVsTINLQKA |
Mus musculus |
MEF Cell |
pmid |
sentence |
31186373 |
AMPK directly activates mTORC2 to promote cell survival during acute energetic stress. AMPK associates with and phosphorylates mTOR within mTORC2., these data indicate that AMPK phosphorylates mTOR on Ser1261 within mTORC2, an event that correlates with increased mTORC2 autophosphorylation and downstream signaling. |
|
Publications: |
1 |
Organism: |
Mus Musculus |
Pathways: | Acute Myeloid Leukemia, IDH-TET in AML, FLT3-ITD signaling, Leptin Signaling, MTOR Signaling |
+ |
MTOR | down-regulates activity
phosphorylation
|
PRKN |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277586 |
Ser127 |
AVILHTDsRKDSPPA |
Homo sapiens |
HEK-293T Cell |
pmid |
sentence |
35191952 |
MTOR phosphorylates PARK2 at Ser127 Through biochemical, mutational, and genetic studies, we identified PARK2 as a mTORC1 substrate. mTORC1 phosphorylates PARK2 at Ser127, which blocks its cellular ubiquitination activity, thereby hindering its tumor suppressor effect on eIF4B's stability. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Parkinson |
+ |
MTOR | up-regulates
phosphorylation
|
ISCU |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-201595 |
Ser14 |
FRLRRAAsALLLRSP |
Homo sapiens |
|
pmid |
sentence |
23508953 |
Here, we demonstrate that mtorc1 associates with iscu and phosphorylates iscu at serine 14. This phosphorylation stabilized iscu protein. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CHUK | up-regulates activity
phosphorylation
|
MTOR |
0.523 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276646 |
Ser1415 |
PTPAILEsLISINNK |
Homo sapiens |
HEK-293T Cell |
pmid |
sentence |
24990947 |
Importantly, IKKα is shown to phosphorylate mTOR at serine 1415 in a manner dependent on Akt to promote mTORC1 activity. These results demonstrate that IKKα is an effector of Akt in promoting mTORC1 activity. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates activity
phosphorylation
|
TFEB |
0.492 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255310 |
Ser142 |
AGNSAPNsPMAMLHI |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
22343943 |
Here, we have used an mTORC1 in-vitro kinase assay and a phosphoantibody to demonstrate that serine S142, which we previously found to be phosphorylated by ERK2, is also phosphorylated by mTOR and that this phosphorylation has a crucial role in controlling TFEB subcellular localization and activity. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-248270 |
Ser211 |
LVGVTSSsCPADLTQ |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
22692423 |
Our data points to the lysosome as the site where mTORC1-dependent phosphorylation of TFEB occurs. [...]Our study has revealed a specific role for phosphorylation of TFEB S211 in the negative regulation of the nuclear abundance of TFEB. This occurs through the promotion of 14-3-3 binding and the masking of the nearby NLS on TFEB. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
MTOR | down-regulates activity
phosphorylation
|
AKT1S1 |
0.901 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-178120 |
Ser183 |
PTQQYAKsLPVSVPV |
in vitro |
|
pmid |
sentence |
18372248 |
Pras40 functions as a negative regulator when bound to mtorc1, and it dissociates from mtorc1 in response to insulin. Pras40 has been demonstrated to be a substrate of mtorc1, and one phosphorylation site, ser-183, has been identified. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-154956 |
Ser183 |
PTQQYAKsLPVSVPV |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
17517883 |
The proline-rich Akt substrate of 40 kilodaltons (PRAS40) was identified as a raptor-binding protein that is phosphorylated directly by mammalian target of rapamycin (mTOR) complex 1 (mTORC1) but not mTORC2 in vitro, predominantly at PRAS40 (Ser(183)).PRAS40 binding to raptor was also abolished by mutation of the major mTORC1 phosphorylation site, Ser(183), to Asp. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-178124 |
Ser212 |
EENGPPSsPDLDRIA |
in vitro |
|
pmid |
sentence |
18372248 |
In this study, we used two-dimensional phosphopeptide mapping in conjunction with mutational analysis to show that in addition to ser-183, mtorc1 also phosphorylates ser-212 and ser-221 in pras40 when assayed in vitro. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-178128 |
Ser221 |
DLDRIAAsMRALVLR |
in vitro |
|
pmid |
sentence |
18372248 |
We propose that after mtorc1 kinase activation by upstream regulators, pras40 is phosphorylated directly by mtor, thus contributing to the relief of pras40-mediated substrate competitionwe also find that mutation of ser-221 to ala increases the inhibitory activity of pras40 toward mtorc1. |
|
Publications: |
4 |
Organism: |
In Vitro, Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
RPS6K | down-regulates activity
phosphorylation
|
MTOR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-137251 |
Ser2448 |
RSRTRTDsYSAGQSV |
Homo sapiens |
|
pmid |
sentence |
15905173 |
Importantly, phosphorylation of mTOR by S6K1 occurs at threonine 2446/serine 2448. This region has been shown previously to be part of a regulatory repressor domain. These sites are also constitutively phosphorylated in the breast cancer cell line MCF7 carrying an amplification of the S6K1 geneit has been proposed that other inputs, in addition to phosphorylation of Thr-2446/Ser-2448 by S6K1, are part of the mechanism involved in inhibiting this repressor domain |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-137255 |
Thr2446 |
NKRSRTRtDSYSAGQ |
Homo sapiens |
|
pmid |
sentence |
15905173 |
Importantly, phosphorylation of mTOR by S6K1 occurs at threonine 2446/serine 2448. This region has been shown previously to be part of a regulatory repressor domain. These sites are also constitutively phosphorylated in the breast cancer cell line MCF7 carrying an amplification of the S6K1 geneit has been proposed that other inputs, in addition to phosphorylation of Thr-2446/Ser-2448 by S6K1, are part of the mechanism involved in inhibiting this repressor domain |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, Leptin Signaling |
+ |
AKT1 |
phosphorylation
|
MTOR |
0.928 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251099 |
Ser2448 |
RSRTRTDsYSAGQSV |
Homo sapiens |
|
pmid |
sentence |
10910062 |
Although AKT phosphorylated mTOR at two COOH-terminal sites (Thr2446 and Ser2448) in vitro, Ser2448 was the major phosphorylation site in insulin-stimulated or -activated AKT-expressing human embryonic kidney cells. Transient transfection assays with mTOR mutants bearing Ala substitutions at Ser2448 and/or Thr2446 indicated that AKT-dependent mTOR phosphorylation was not essential for either PHAS-I phosphorylation or p70S6K activation in HEK cells. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, Glioblastoma Multiforme, Parkinson |
+ |
AKT |
phosphorylation
|
MTOR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-244311 |
Ser2448 |
RSRTRTDsYSAGQSV |
Homo sapiens |
|
pmid |
sentence |
10910062 |
AKT phosphorylated mTOR at two COOH-terminal sites (Thr2446 and Ser2448) in vitro, Ser2448 was the major phosphorylation site in insulin-stimulated or -activated AKT-expressing human embryonic kidney cells. These results demonstrate that mTOR is a direct target of the PI3K-AKT signaling pathway in mitogen-stimulated cells, and that the identified AKT phosphorylation sites are nested within a repressor domain that negatively regulates the catalytic activity of mTOR.  |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251482 |
Thr2446 |
NKRSRTRtDSYSAGQ |
Homo sapiens |
|
pmid |
sentence |
10910062 |
AKT phosphorylated mTOR at two COOH-terminal sites (Thr2446 and Ser2448) in vitro, Ser2448 was the major phosphorylation site in insulin-stimulated or -activated AKT-expressing human embryonic kidney cells. These results demonstrate that mTOR is a direct target of the PI3K-AKT signaling pathway in mitogen-stimulated cells, and that the identified AKT phosphorylation sites are nested within a repressor domain that negatively regulates the catalytic activity of mTOR.  |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, BCR-ABL in AML, FLT3 in AML, KIT in AML, miRNA in AML, FLT3-ITD in AML, FLT3-ITD signaling, Glioblastoma Multiforme, Leptin Signaling, MTOR Signaling, Pancreatic ductal adenocarcinoma (PDA) |
+ |
MTOR | up-regulates activity
phosphorylation
|
MTOR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-75394 |
Ser2481 |
TVPESIHsFIGDGLV |
Homo sapiens |
T-lymphocyte |
pmid |
sentence |
10702316 |
We report here the identification of a FRAP autophosphorylation site. This site, Ser-2481, is located in a hydrophobic region near the conserved carboxyl-terminal FRAP tail. We demonstrate that the COOH-terminal tail is required for FRAP kinase activity and for signaling to the translational regulator p70(s6k) (ribosomal subunit S6 kinase). |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-235427 |
Ser2481 |
TVPESIHsFIGDGLV |
Mus musculus |
NIH-3T3 Cell |
pmid |
sentence |
20022946 |
We have found that in HEK293 cells and 3T3-L1 adipocytes, insulin promotes both raptor- and rictor-associated mTOR Ser(P)-2481 in a wortmannin-sensitive manner. Thus, insulin signals via PI3K to promote both mTORC1- and mTORC2-associated mTOR Ser-2481 autophosphorylation. |
|
Publications: |
2 |
Organism: |
Homo Sapiens, Mus Musculus |
Pathways: | Acute Myeloid Leukemia, BCR-ABL in AML, FLT3 in AML, IDH-TET in AML, KIT in AML, miRNA in AML, FLT3-ITD in AML, FLT3-ITD signaling, Glioblastoma Multiforme, Leptin Signaling, MTOR Signaling, Parkinson, Pancreatic ductal adenocarcinoma (PDA), Rett syndrome |
+ |
MTOR | down-regulates
phosphorylation
|
DEPTOR |
0.747 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-176849 |
Ser293 |
SSGYFSSsPTLSSSP |
Homo sapiens |
|
pmid |
sentence |
22017875 |
Our data reveal critical roles for mtor itself as well as cki in generating a degron in deptor that is recognized by _-trcp, and promotes deptor turnover by the proteasome. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-176853 |
Ser299 |
SSPTLSSsPPVLCNP |
Homo sapiens |
|
pmid |
sentence |
22017875 |
Our data reveal critical roles for mtor itself as well as cki in generating a degron in deptor that is recognized by _-trcp, and promotes deptor turnover by the proteasome. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates activity
phosphorylation
|
DAP |
0.405 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-259813 |
Ser3 |
DQEWESPsPPKPTVF |
Homo sapiens |
|
pmid |
sentence |
20537536 |
A critical step in autophagy induction comprises the inactivation of a key negative regulator of the process, the Ser/Thr kinase mammalian target of rapamycin (mTOR). Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy. Mapping of the phosphorylation sites and analysis of phosphorylation mutants indicated that DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-259812 |
Ser51 |
DQEWESPsPPKPTVF |
Homo sapiens |
|
pmid |
sentence |
20537536 |
A critical step in autophagy induction comprises the inactivation of a key negative regulator of the process, the Ser/Thr kinase mammalian target of rapamycin (mTOR). Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy. Mapping of the phosphorylation sites and analysis of phosphorylation mutants indicated that DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates activity
phosphorylation
|
IRS1 |
0.758 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-106570 |
Ser307 |
TRRSRTEsITATSPA |
Rattus norvegicus |
Fibroblast |
pmid |
sentence |
11287630 |
Mtor induced the serine phosphorylation of irs-1 (ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that tnf impairs insulin signaling through irs-1 by activation of a pi 3-kinase/akt/mtor pathway, which is antagonized by pten |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-52700 |
Ser307 |
TRRSRTEsITATSPA |
Homo sapiens |
|
pmid |
sentence |
9335553 |
These results indicate that activation of protein kinase c stimulates a kinase which can phosphorylate insulin receptor substrate-1 at serine 612, resulting in an inhibition of insulin signaling in the cell these data suggest that: 1) activation of pkctheta contributes to ikk and jnk activation by ffas;2) ikk and jnk mediate pkctheta signals for irs-1 serine phosphorylation and degradation; ser-302 phosphorylation is dependent on pi 3-kinase/mtor, whereas ser-307 depends on c-jun nh2-terminal kinase to inhibit irs1 tyrosine phosphorylation. Ser-636 is located around the pi 3-kinase binding site and, therefore, thought to inhibit pi 3-kinase signaling. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-106574 |
Ser312 |
TESITATsPASMVGG |
Rattus norvegicus |
Fibroblast |
pmid |
sentence |
11287630 |
Mtor induced the serine phosphorylation of irs-1 (ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that tnf impairs insulin signaling through irs-1 by activation of a pi 3-kinase/akt/mtor pathway, which is antagonized by pten |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-106578 |
Ser315 |
ITATSPAsMVGGKPG |
Rattus norvegicus |
Fibroblast |
pmid |
sentence |
11287630 |
Mtor induced the serine phosphorylation of irs-1 (ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that tnf impairs insulin signaling through irs-1 by activation of a pi 3-kinase/akt/mtor pathway, which is antagonized by pten |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-106582 |
Ser616 |
DDGYMPMsPGVAPVP |
Rattus norvegicus |
|
pmid |
sentence |
11287630 |
Mtor induced the serine phosphorylation of irs-1 (ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that tnf impairs insulin signaling through irs-1 by activation of a pi 3-kinase/akt/mtor pathway, which is antagonized by pten |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-106586 |
Ser636 |
SGDYMPMsPKSVSAP |
Rattus norvegicus |
|
pmid |
sentence |
11287630 |
Mtor induced the serine phosphorylation of irs-1 (ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that tnf impairs insulin signaling through irs-1 by activation of a pi 3-kinase/akt/mtor pathway, which is antagonized by pten |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-106590 |
Ser639 |
YMPMSPKsVSAPQQI |
Rattus norvegicus |
Fibroblast |
pmid |
sentence |
11287630 |
Mtor induced the serine phosphorylation of irs-1 (ser-636/639), and such phosphorylation was inhibited by rapamycin. These results suggest that tnf impairs insulin signaling through irs-1 by activation of a pi 3-kinase/akt/mtor pathway, which is antagonized by pten |
|
Publications: |
7 |
Organism: |
Rattus Norvegicus, Homo Sapiens |
Tissue: |
Kidney |
Pathways: | Leptin Signaling, MTOR Signaling |
+ |
MTOR | up-regulates activity
phosphorylation
|
LARP6 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273679 |
Ser348 |
DPESNPTsPMAGRRH |
Rattus norvegicus |
Hepatic Stellate Cell |
pmid |
sentence |
28112218 |
Binding of La ribonucleoprotein domain family, member 6 (LARP6) to collagen mRNAs regulates their translation and is necessary for high type I collagen expression. Here we show that mTORC1 phosphorylates LARP6 on S348 and S409. The S348A/S409A mutant of LARP6 acts as a dominant negative protein in collagen biosynthesis, which retards secretion of type I collagen and causes excessive posttranslational modifications. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273678 |
Ser409 |
GRLNCSTsPEIFRKC |
Rattus norvegicus |
Hepatic Stellate Cell |
pmid |
sentence |
28112218 |
Binding of La ribonucleoprotein domain family, member 6 (LARP6) to collagen mRNAs regulates their translation and is necessary for high type I collagen expression. Here we show that mTORC1 phosphorylates LARP6 on S348 and S409. The S348A/S409A mutant of LARP6 acts as a dominant negative protein in collagen biosynthesis, which retards secretion of type I collagen and causes excessive posttranslational modifications. |
|
Publications: |
2 |
Organism: |
Rattus Norvegicus |
+ |
MTOR | up-regulates activity
phosphorylation
|
RPS6KB2 |
0.831 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250293 |
Ser370 |
TRQTPVDsPDDTALS |
in vitro |
|
pmid |
sentence |
11733037 |
In vitro phosphorylation and activation of p70β by mTOR and PDK1. replacement of Ser383 to Gly (S383G) reduced but still retained nearly half of the kinase activity of the wild-type. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250294 |
Thr228 |
HEGAVTHtFCGTIEY |
in vitro |
|
pmid |
sentence |
11733037 |
In vitro phosphorylation and activation of p70β by mTOR and PDK1. We observed that the replacement of either Thr241 or Thr401 to Ala in p70β1(T241A, T401A) severely decreased the kinase activity. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250295 |
Thr388 |
NQAFLGFtYVAPSVL |
in vitro |
|
pmid |
sentence |
11733037 |
In vitro phosphorylation and activation of p70β by mTOR and PDK1. We observed that the replacement of either Thr241 or Thr401 to Ala in p70β1(T241A, T401A) severely decreased the kinase activity. |
|
Publications: |
3 |
Organism: |
In Vitro |
+ |
MTOR | up-regulates activity
phosphorylation
|
RPS6KB1 |
0.96 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101328 |
Ser394 |
TRQTPVDsPDDSTLS |
Mus musculus |
MEF Cell |
pmid |
sentence |
12782654 |
S6K1 is a positive regulator of protein synthesis, and its activity is induced by mTOR-mediated phosphorylation. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-201530 |
Ser394 |
TRQTPVDsPDDSTLS |
Sus scrofa |
|
pmid |
sentence |
23486913 |
Collectively, these results indicate that Arg, Leu, and Gln act coordinately to stimulate proliferation of pTr cells through activation of the MTOR-RPS6K-RPS6-EIF4EBP1 signal transduction pathway |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-201534 |
Ser434 |
SFEPKIRsPRRFIGS |
Sus scrofa |
|
pmid |
sentence |
23486913 |
Collectively, these results indicate that Arg, Leu, and Gln act coordinately to stimulate proliferation of pTr cells through activation of the MTOR-RPS6K-RPS6-EIF4EBP1 signal transduction pathway |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101332 |
Ser434 |
SFEPKIRsPRRFIGS |
Mus musculus |
MEF Cell |
pmid |
sentence |
12782654 |
S6K1 is a positive regulator of protein synthesis, and its activity is induced by mTOR-mediated phosphorylation. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255839 |
Thr390 |
DSKFTRQtPVDSPDD |
Homo sapiens |
|
pmid |
sentence |
11914378 |
Thr229 phosphorylation requires prior phosphorylation of the Ser/Thr-Pro sites in the autoinhibitory domain and Thr389 in the linker domain,[…] Moreover, in vitro mTOR directly phosphorylates Ser371, and this event modulates Thr389phosphorylation by mTOR, compatible with earlier in vivo findings. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-201538 |
Thr412 |
NQVFLGFtYVAPSVL |
Sus scrofa |
|
pmid |
sentence |
23486913 |
Collectively, these results indicate that Arg, Leu, and Gln act coordinately to stimulate proliferation of pTr cells through activation of the MTOR-RPS6K-RPS6-EIF4EBP1 signal transduction pathway |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101336 |
Thr412 |
NQVFLGFtYVAPSVL |
Mus musculus |
MEF Cell |
pmid |
sentence |
12782654 |
S6K1 is a positive regulator of protein synthesis, and its activity is induced by mTOR-mediated phosphorylation. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-72357 |
Thr412 |
NQVFLGFtYVAPSVL |
in vitro |
|
pmid |
sentence |
10567431 |
We report here that a mammalian recombinant p70alpha polypeptide, extracted in an inactive form from rapamycin-treated cells, can be directly phosphorylated by the mTOR kinase in vitro predominantly at the rapamycin-sensitive site Thr-412. mTOR-catalyzed p70alpha phosphorylation in vitro is accompanied by a substantial restoration in p70alpha kinase activity toward its physiologic substrate |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-72682 |
Thr412 |
NQVFLGFtYVAPSVL |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
10579915 |
S6 kinases are under the control of the PI3K relative, mammalian Target Of Rapamycin (mTOR), which may serve an additional function as a checkpoint for amino acid availability. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-235507 |
Thr412 |
NQVFLGFtYVAPSVL |
Mus musculus |
NIH-3T3 Cell |
pmid |
sentence |
17510057 |
mTORC1 catalyzes the phosphorylation of eIF4E binding protein-1 (4EBP1, also known as PHAS-I) and p70 S6 kinase 1 (S6K1)Phosphorylation of S6K1 at Thr-389 |
|
Publications: |
10 |
Organism: |
Mus Musculus, Sus Scrofa, Homo Sapiens, In Vitro |
Tissue: |
Parathyroid Hormone Secreting Cell |
Pathways: | FLT3-ITD signaling, MTOR Signaling |
+ |
MTOR | up-regulates
phosphorylation
|
SGK1 |
0.844 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-179113 |
Ser422 |
AEAFLGFsYAPPTDS |
Homo sapiens |
|
pmid |
sentence |
18570873 |
Mtor phosphorylated sgk1, but not sgk1-s422a, in vitro. Sgk1 phosphorylated p27 in vitro. These data implicate sgk1 as an mtorc1 (mtor-raptor) substrate. mtor may promote g1 progression in part through sgk1 activation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-181531 |
Ser422 |
AEAFLGFsYAPPTDS |
Homo sapiens |
|
pmid |
sentence |
18925875 |
Mtorc2 immunoprecipitated from wild-type, but not from mlst8- or rictor-knockout cells, phosphorylated sgk1 at ser(422) |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
MTOR | up-regulates activity
phosphorylation
|
AKT1 |
0.928 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-252599 |
Ser473 |
RPHFPQFsYSASGTA |
Homo sapiens |
HT-29 Cell, A-549 Cell |
pmid |
sentence |
15718470 |
The rictor-mtor complex directly phosphorylated akt/pkb on ser473 in vitro and facilitated thr308 phosphorylation by pdk1 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-170604 |
Ser473 |
RPHFPQFsYSASGTA |
Homo sapiens |
|
pmid |
sentence |
21157483 |
Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt.Recent findings have revealed novel important roles for mTORC2 in the phosphorylation of AGC kinase family members. mTORC2 phosphorylates and activates Akt, SGK, and PKC, which regulate cell survival, cell cycle progression and anabolism |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-217869 |
Ser473 |
RPHFPQFsYSASGTA |
Homo sapiens |
Blood Platelet |
pmid |
sentence |
21592956 |
Protein kinase B (PKB, Akt) is a Ser/Thr kinase involved in the regulation of cell survival, proliferation, and metabolism and is activated by dual phosphorylation on Thr(308) in the activation loop and Ser(473) in the hydrophobic motif. It plays a contributory role to platelet function, although little is known about its regulation. In this study, we investigated the role of the mammalian target of rapamycin complex (mTORC)-2 in Akt regulation using the recently identified small molecule ATP competitive mTOR inhibitors PP242 and Torin1. |
|
Publications: |
3 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, Glioblastoma Multiforme, Parkinson |
+ |
MTOR | up-regulates activity
phosphorylation
|
AKT |
0.928 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-134185 |
Ser473 |
RPHFPQFsYSASGTA |
Homo sapiens |
HT-29 Cell, A-549 Cell |
pmid |
sentence |
15718470 |
The rictor-mtor complex directly phosphorylated akt/pkb on ser473 in vitro and facilitated thr308 phosphorylation by pdk1 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-244417 |
|
|
Homo sapiens |
Blood Platelet |
pmid |
sentence |
21592956 |
Protein kinase B (PKB, Akt) is a Ser/Thr kinase involved in the regulation of cell survival, proliferation, and metabolism and is activated by dual phosphorylation on Thr(308) in the activation loop and Ser(473) in the hydrophobic motif. It plays a contributory role to platelet function, although little is known about its regulation. In this study, we investigated the role of the mammalian target of rapamycin complex (mTORC)-2 in Akt regulation using the recently identified small molecule ATP competitive mTOR inhibitors PP242 and Torin1. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, BCR-ABL in AML, FLT3 in AML, KIT in AML, miRNA in AML, FLT3-ITD in AML, FLT3-ITD signaling, Glioblastoma Multiforme, Leptin Signaling, MTOR Signaling, Pancreatic ductal adenocarcinoma (PDA) |
+ |
MTOR | down-regulates activity
phosphorylation
|
AMBRA1 |
0.484 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-272986 |
Ser52 |
KRVELPDsPRSTFLL |
|
|
pmid |
sentence |
23524951 |
We show that under non-autophagic conditions, mTOR inhibits AMBRA1 by phosphorylation, whereas on autophagy induction, AMBRA1 is dephosphorylated. In this condition, AMBRA1, interacting with the E3-ligase TRAF6, supports ULK1 ubiquitylation by LYS-63-linked chains, and its subsequent stabilization, self-association and function. As ULK1 has been shown to activate AMBRA1 by phosphorylation, the proposed pathway may act as a positive regulation loop, which may be targeted in human disorders linked to impaired autophagy.|mTOR phosphorylates AMBRA1 at Ser 52, inhibiting its role in ULK1 modification |
|
Publications: |
1 |
+ |
MTOR | up-regulates activity
phosphorylation
|
UVRAG |
0.419 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276920 |
Ser550 |
KITSLSSsLDTSLDF |
Homo sapiens |
U2-OS Cell |
pmid |
sentence |
26139536 |
MTOR phosphorylates UVRAG at serine 550 and serine 571 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276919 |
Ser571 |
KGEDLVGsLNGGHAN |
Homo sapiens |
U2-OS Cell |
pmid |
sentence |
26139536 |
MTOR phosphorylates UVRAG at serine 550 and serine 571 |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates
phosphorylation
|
MAF1 |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-165791 |
Ser60 |
PHVLEALsPPQTSGL |
Homo sapiens |
|
pmid |
sentence |
20516213 |
The protein is phosphorylated mainly on residues s60, s68, and s75, and this inhibits its pol iii repression function. The responsible kinase is mtorc1, which phosphorylates maf1 directly. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-164348 |
Ser68 |
PPQTSGLsPSRLSKS |
Homo sapiens |
|
pmid |
sentence |
20233713 |
The identification of maf1 as an mtor-regulated phosphoprotein implicates mtor in the broader regulatory mechanisms governing pol iii activity in cancer cells. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-165795 |
Ser68 |
PPQTSGLsPSRLSKS |
Homo sapiens |
|
pmid |
sentence |
20516213 |
The protein is phosphorylated mainly on residues s60, s68, and s75, and this inhibits its pol iii repression function. The responsible kinase is mtorc1, which phosphorylates maf1 directly. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-164352 |
Ser75 |
SPSRLSKsQGGEEEG |
Homo sapiens |
|
pmid |
sentence |
20233713 |
Employing an mtor active-site inhibitor wye-125132 (wye-132), we have performed quantitative phospho-proteomics and identified a ser-75-containing phosphopeptide from maf1, a known repressor of rna polymerase iii (pol iii) transcriptionmaf1 mutant proteins carrying s75a alone or with s60a, t64a, and s68a (maf1-s75a, maf1-4a) progressively enhanced basal repression of trna in actively proliferating cells and attenuated amino acid-induced trna transcription |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-166054 |
Ser75 |
SPSRLSKsQGGEEEG |
Homo sapiens |
HeLa Cell |
pmid |
sentence |
20543138 |
Maf1, a repressor that binds and inhibits pol iii, is phosphorylated in a mtor-dependent manner both in vitro and in vivo at serine 75 |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-165799 |
Ser75 |
SPSRLSKsQGGEEEG |
Homo sapiens |
|
pmid |
sentence |
20516213 |
The protein is phosphorylated mainly on residues s60, s68, and s75, and this inhibits its pol iii repression function. The responsible kinase is mtorc1, which phosphorylates maf1 directly. |
|
Publications: |
6 |
Organism: |
Homo Sapiens |
+ |
MTOR | up-regulates activity
phosphorylation
|
DNM1L |
0.352 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-275430 |
Ser616 |
PIPIMPAsPQKGHAV |
Homo sapiens |
JURKAT Cell |
pmid |
sentence |
34535949 |
Furthermore, we confirmed also in Jurkat cells that the specific silencing of both ERK1/2 and mTOR by siRNA downregulates Drp1 phosphorylation on Ser616 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates activity
phosphorylation
|
EIF4EBP1 |
0.924 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-226714 |
Ser65 |
FLMECRNsPVTKTPP |
Homo sapiens |
HEK-293T Cell |
pmid |
sentence |
10942774 |
PHAS-I in adipocytes and HEK293 cells is phosphorylated in the following five sites, all of which conform to a (S/T)P motif (9, 10): Thr-36, Thr-45, Ser-64, Thr-69, and Ser-82. Thr-45 and Ser-64 flank the eIF4E-binding motif (7, 8), and phosphorylation of either site blocks eIF4E binding in vitro (10, 11). Insulin stimulates the phosphorylation of Thr-36, Thr-45, Ser-64, and Thr-69 in both fat cells and HEK293 cells, and incubating cells with rapamycin decreases the phosphorylation of these sites.Immunoprecipitated epitope-tagged mammalian target of rapamycin (mTOR) phosphorylated Thr-36/45. mTOR also phosphorylated Thr-69 and Ser-64 but only when purified immune complexes were incubated with the activating antibody, mTAb1. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-219257 |
Ser65 |
FLMECRNsPVTKTPP |
Sus scrofa |
Trophectoderm |
pmid |
sentence |
23486913 |
These results indicate that arg, leu, and gln act coordinately to stimulate proliferation of ptr cells through activation of the mtor-rps6k-rps6-eif4ebp1 signal transduction pathway. Specifically as part of mtorc1, mtor directly phosphorylates the ribosomal protein s6 kinases (s6k1 and s6k2) and the eukaryotic initiation factor 4e (eif4e)-binding proteins (4e-bp1 and 4e-bp2), both of which control specific steps in the initiation of cap-dependent translation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101115 |
Ser65 |
FLMECRNsPVTKTPP |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
12747827 |
Here, we show that a functional TOS motif is required for 4E-BP1 to bind to raptor (a recently identified mTOR-interacting protein), for 4E-BP1 to be efficiently phosphorylated in vitro by themTOR/raptor complex, and for 4E-BP1 to be phosphorylated in vivo at all identified mTOR-regulated sites. mTOR/raptor regulated phosphorylation is necessary for 4E-BPs efficient release from the translational initiation factor eIF4E. We find that the TOS motif is absolutely required for efficient phosphorylation of 4E-BP1 at all the identified mTOR-regulated sites, namely, Thr37/46, Ser65, and Thr70 in vivo. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250292 |
Ser83 |
PTIPGVTsPSSDEPP |
Homo sapiens |
|
pmid |
sentence |
9204908 |
MTOR phosphorylated PHAS-I on serine and threonine residues in vitro, and these modifications inhibited the binding of PHAS-I to eIF-4E. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-154810 |
Thr36 |
LPPGDYStTPGGTLF |
Homo sapiens |
|
pmid |
sentence |
17510057 |
In response to insulin and nutrients, mTORC1, consisting of mTOR, raptor (regulatory-associated protein of mTOR), and mLST8, is activated and phosphorylates eukaryotic initiation factor 4E-binding protein (4EBP) and p70 S6 kinase to promote protein synthesis and cell size. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-167180 |
Thr36 |
LPPGDYStTPGGTLF |
Mus musculus |
MEF Cell |
pmid |
sentence |
20670887 |
Specifically as part of mTORC1, mTOR directly phosphorylates the ribo- somal protein S6 kinases (S6K1 and S6K2) and the eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BP1 and 4E-BP2), both of which control specific steps in the initiation of cap-dependent translation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-55697 |
Thr36 |
LPPGDYStTPGGTLF |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
9465032 |
Mtorc1 promotes protein synthesis by phosphorylating the eukaryotic initiation factor 4e (eif4e)- binding protein 1 (4e-bp1) and the p70 ribosomal s6 kinase 1 (s6k1). Raft1 phosphorylation of 4e-bp1 on thr-36 and thr-45 blocks its association with the cap-binding protein, eif-4e,in vitro. in response to insulin and nutrients, mtorc1, consisting of mtor, raptor (regulatory-associated protein of mtor), and mlst8, is activated and phosphorylates eukaryotic initiation factor 4e-binding protein (4ebp) and p70 s6 kinase to promote protein synthesis and cell size. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101119 |
Thr37 |
PPGDYSTtPGGTLFS |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
12747827 |
Here, we show that a functional TOS motif is required for 4E-BP1 to bind to raptor (a recently identified mTOR-interacting protein), for 4E-BP1 to be efficiently phosphorylated in vitro by themTOR/raptor complex, and for 4E-BP1 to be phosphorylated in vivo at all identified mTOR-regulated sites. mTOR/raptor regulated phosphorylation is necessary for 4E-BPs efficient release from the translational initiation factor eIF4E. We find that the TOS motif is absolutely required for efficient phosphorylation of 4E-BP1 at all the identified mTOR-regulated sites, namely, Thr37/46, Ser65, and Thr70 in vivo. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-219262 |
Thr37 |
PPGDYSTtPGGTLFS |
Sus scrofa |
Trophectoderm |
pmid |
sentence |
23486913 |
These results indicate that arg, leu, and gln act coordinately to stimulate proliferation of ptr cells through activation of the mtor-rps6k-rps6-eif4ebp1 signal transduction pathway. Specifically as part of mtorc1, mtor directly phosphorylates the ribosomal protein s6 kinases (s6k1 and s6k2) and the eukaryotic initiation factor 4e (eif4e)-binding proteins (4e-bp1 and 4e-bp2), both of which control specific steps in the initiation of cap-dependent translation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-154814 |
Thr45 |
PGGTLFStTPGGTRI |
Homo sapiens |
HEK-293 Cell, Adipocyte |
pmid |
sentence |
17510057 |
In response to insulin and nutrients, mTORC1, consisting of mTOR, raptor (regulatory-associated protein of mTOR), and mLST8, is activated and phosphorylates eukaryotic initiation factor 4E-binding protein (4EBP) and p70 S6 kinase to promote protein synthesis and cell size. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-167184 |
Thr45 |
PGGTLFStTPGGTRI |
Mus musculus |
MEF Cell |
pmid |
sentence |
20670887 |
Specifically as part of mTORC1, mTOR directly phosphorylates the ribo- somal protein S6 kinases (S6K1 and S6K2) and the eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BP1 and 4E-BP2), both of which control specific steps in the initiation of cap-dependent translation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-55701 |
Thr45 |
PGGTLFStTPGGTRI |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
9465032 |
Mtorc1 promotes protein synthesis by phosphorylating the eukaryotic initiation factor 4e (eif4e)- binding protein 1 (4e-bp1) and the p70 ribosomal s6 kinase 1 (s6k1). Raft1 phosphorylation of 4e-bp1 on thr-36 and thr-45 blocks its association with the cap-binding protein, eif-4e,in vitro. in response to insulin and nutrients, mtorc1, consisting of mtor, raptor (regulatory-associated protein of mtor), and mlst8, is activated and phosphorylates eukaryotic initiation factor 4e-binding protein (4ebp) and p70 s6 kinase to promote protein synthesis and cell size. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-219266 |
Thr46 |
GGTLFSTtPGGTRII |
Sus scrofa |
Trophectoderm |
pmid |
sentence |
23486913 |
These results indicate that arg, leu, and gln act coordinately to stimulate proliferation of ptr cells through activation of the mtor-rps6k-rps6-eif4ebp1 signal transduction pathway. Specifically as part of mtorc1, mtor directly phosphorylates the ribosomal protein s6 kinases (s6k1 and s6k2) and the eukaryotic initiation factor 4e (eif4e)-binding proteins (4e-bp1 and 4e-bp2), both of which control specific steps in the initiation of cap-dependent translation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101123 |
Thr46 |
GGTLFSTtPGGTRII |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
12747827 |
Here, we show that a functional TOS motif is required for 4E-BP1 to bind to raptor (a recently identified mTOR-interacting protein), for 4E-BP1 to be efficiently phosphorylated in vitro by themTOR/raptor complex, and for 4E-BP1 to be phosphorylated in vivo at all identified mTOR-regulated sites. mTOR/raptor regulated phosphorylation is necessary for 4E-BPs efficient release from the translational initiation factor eIF4E. We find that the TOS motif is absolutely required for efficient phosphorylation of 4E-BP1 at all the identified mTOR-regulated sites, namely, Thr37/46, Ser65, and Thr70 in vivo. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-219273 |
Thr70 |
RNSPVTKtPPRDLPT |
Sus scrofa |
Trophectoderm |
pmid |
sentence |
23486913 |
These results indicate that arg, leu, and gln act coordinately to stimulate proliferation of ptr cells through activation of the mtor-rps6k-rps6-eif4ebp1 signal transduction pathway. Specifically as part of mtorc1, mtor directly phosphorylates the ribosomal protein s6 kinases (s6k1 and s6k2) and the eukaryotic initiation factor 4e (eif4e)-binding proteins (4e-bp1 and 4e-bp2), both of which control specific steps in the initiation of cap-dependent translation |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101127 |
Thr70 |
RNSPVTKtPPRDLPT |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
12747827 |
Here, we show that a functional TOS motif is required for 4E-BP1 to bind to raptor (a recently identified mTOR-interacting protein), for 4E-BP1 to be efficiently phosphorylated in vitro by themTOR/raptor complex, and for 4E-BP1 to be phosphorylated in vivo at all identified mTOR-regulated sites. mTOR/raptor regulated phosphorylation is necessary for 4E-BPs efficient release from the translational initiation factor eIF4E. We find that the TOS motif is absolutely required for efficient phosphorylation of 4E-BP1 at all the identified mTOR-regulated sites, namely, Thr37/46, Ser65, and Thr70 in vivo. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-80797 |
Thr70 |
RNSPVTKtPPRDLPT |
Homo sapiens |
|
pmid |
sentence |
10942774 |
Mammalian target of rapamycin-dependent phosphorylation of phas-i in four (s/t)p sites detected by phospho-specific antibodies. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-226710 |
Thr70 |
RNSPVTKtPPRDLPT |
Homo sapiens |
HEK-293T Cell |
pmid |
sentence |
10942774 |
PHAS-I in adipocytes and HEK293 cells is phosphorylated in the following five sites, all of which conform to a (S/T)P motif (9, 10): Thr-36, Thr-45, Ser-64, Thr-69, and Ser-82. Thr-45 and Ser-64 flank the eIF4E-binding motif (7, 8), and phosphorylation of either site blocks eIF4E binding in vitro (10, 11). Insulin stimulates the phosphorylation of Thr-36, Thr-45, Ser-64, and Thr-69 in both fat cells and HEK293 cells, and incubating cells with rapamycin decreases the phosphorylation of these sites.Immunoprecipitated epitope-tagged mammalian target of rapamycin (mTOR) phosphorylated Thr-36/45. mTOR also phosphorylated Thr-69 and Ser-64 but only when purified immune complexes were incubated with the activating antibody, mTAb1. |
|
Publications: |
18 |
Organism: |
Homo Sapiens, Sus Scrofa, Mus Musculus |
Pathways: | MTOR Signaling |
+ |
MTOR | up-regulates
phosphorylation
|
STAT3 |
0.738 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-146915 |
Ser727 |
NTIDLPMsPRTLDSL |
Homo sapiens |
Glioblastoma Cell |
pmid |
sentence |
16740698 |
Serine phosphorylation and maximal activation of stat3 during cntf signaling is mediated by the rapamycin target mtor. / a stat3 peptide was efficiently phosphorylated on ser727 in a cntf-dependent manner by mtor |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-161439 |
Ser727 |
NTIDLPMsPRTLDSL |
Homo sapiens |
|
pmid |
sentence |
18691976 |
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, KIT in AML, FLT3-ITD signaling, Leptin Signaling, Pancreatic ductal adenocarcinoma (PDA) |
+ |
MTOR | down-regulates activity
phosphorylation
|
MKNK2 |
0.278 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277516 |
Ser74 |
KRGRATDsFSGRFED |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
32170339 |
MTOR phosphorylates MNK2a on Ser74. Here, we show that mTORC1, a key regulator of mRNA translation and oncogenesis, directly phosphorylates MNK2 on Ser74. This suppresses MNK2 activity and impairs binding of MNK2 to eIF4G. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates activity
phosphorylation
|
ULK1 |
0.844 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-172541 |
Ser758 |
PVVFTVGsPPSGSTP |
Homo sapiens |
U2-OS Cell |
pmid |
sentence |
21383122 |
When cells are replenished with rich medium, mtor is activated;it phosphorylates serine 638 and serine 758. The phosphorylation of ulk1 at serine 758 then leads to reassociation between ulk1 and ampk. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-187611 |
|
|
Homo sapiens |
|
pmid |
sentence |
19690328 |
The complementary inhibitory mechanism in which mtorc1 phosphorylates the autophagy regulatory complex containing unc-51-like kinase 1 (ulk1), the mammalian atg13 protein, and focal adhesion kinase interacting protein of 200 kd (fip200) has also been elucidated. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-183903 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
21460634 |
mTORC1, which is often referred to as the gatekeeper to autophagy, is a key regulator of the Ulk1-Atg13-FIP200 kinase complex.11,14,25 Under nutrient-rich conditions, active mTORC1 associates with and inactivates the Ulk1-Atg13-FIP200 complex by phosphorylating Ulk1 and Atg13. |
|
Publications: |
3 |
Organism: |
Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
MTOR | down-regulates activity
phosphorylation
|
AMOTL2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-272086 |
Ser759 |
SSSQRAAsLDSVATS |
|
|
pmid |
sentence |
25998128 |
AMOTL2 is phosphorylated at serine 760 by mTORC2. Mutation of AMOTL2 mimicking constitutive Ser(760) phosphorylation blocks its ability to bind and repress YAP leading to increased relative expression of known YAP gene targets. |
|
Publications: |
1 |
+ |
MTOR | up-regulates activity
phosphorylation
|
RPTOR |
0.989 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-174882 |
Ser855 |
QRVLDTSsLTQSAPA |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
19864431 |
Strikingly, raptor Ser(863) phosphorylation is absolutely required for raptor Ser(859) and Ser(855) phosphorylation. These data suggest that mTORC1 activation leads to raptor multisite phosphorylation and that raptor Ser(863) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation (e.g. on Ser(859) and Ser(855)) |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-188920 |
Ser859 |
DTSSLTQsAPASPTN |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
19864431 |
Strikingly, raptor Ser(863) phosphorylation is absolutely required for raptor Ser(859) and Ser(855) phosphorylation. These data suggest that mTORC1 activation leads to raptor multisite phosphorylation and that raptor Ser(863) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation (e.g. on Ser(859) and Ser(855)) |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-184959 |
Ser859 |
DTSSLTQsAPASPTN |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
19346248 |
The phosphorylation of raptor is stimulated by insulin and inhibited by rapamycin. Importantly, the site-directed mutation of raptor at one phosphorylation site, Ser(863), reduced mTORC1 activity both in vitro and in vivo. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-188924 |
Ser863 |
LTQSAPAsPTNKGVH |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
19864431 |
Our data that insulin-stimulated raptor ser863 phosphorylation requires kinase-active mtorc1 and displays rapamycin sensitivity in intact cells, together with the data of wang et al. (67) that mtor phosphorylates raptor ser863 in vitro, strongly suggest that mtor itself mediates raptor ser863 phosphorylation. / strikingly, raptor ser863 phosphorylation is absolutely required for raptor ser859 and ser855 phosphorylation. These data suggest that mtorc1 activation leads to raptor multisite phosphorylation and that raptor ser863 phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation |
|
Publications: |
4 |
Organism: |
Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
RPS6KB1 | down-regulates activity
phosphorylation
|
MTOR |
0.96 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-102051 |
Thr2446 |
NKRSRTRtDSYSAGQ |
Homo sapiens |
|
pmid |
sentence |
15905173 |
Importantly, phosphorylation of mTOR by S6K1 occurs at threonine 2446/serine 2448. This region has been shown previously to be part of a regulatory repressor domain. These sites are also constitutively phosphorylated in the breast cancer cell line MCF7 carrying an amplification of the S6K1 geneit has been proposed that other inputs, in addition to phosphorylation of Thr-2446/Ser-2448 by S6K1, are part of the mechanism involved in inhibiting this repressor domain |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, MTOR Signaling |
+ |
MTOR | up-regulates activity
phosphorylation
|
RPS6K |
0.553 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255841 |
Thr390 |
DSKFTRQtPVDSPDD |
Homo sapiens |
|
pmid |
sentence |
11914378 |
Thr229 phosphorylation requires prior phosphorylation of the Ser/Thr-Pro sites in the autoinhibitory domain and Thr389 in the linker domain,[…] Moreover, in vitro mTOR directly phosphorylates Ser371, and this event modulates Thr389phosphorylation by mTOR, compatible with earlier in vivo findings. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, Leptin Signaling |
+ |
AKT | up-regulates
|
MTOR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-244314 |
|
|
Homo sapiens |
|
pmid |
sentence |
12782654 |
It was shown recently that akt activates mtor through direct phosphorylation of tsc2 the serine/threonine kinase akt is an upstream positive regulator of the mammalian target of rapamycin (mtor). However, the mechanism by which akt activates mtor is not fully understood. The known pathway by which akt activates mtor is via direct phosphorylation and tuberous sclerosis complex 2 (tsc2), which is a negative regulator of mtor. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Skeletal Muscle |
Pathways: | Acute Myeloid Leukemia, BCR-ABL in AML, FLT3 in AML, KIT in AML, miRNA in AML, FLT3-ITD in AML, FLT3-ITD signaling, Glioblastoma Multiforme, Leptin Signaling, MTOR Signaling, Pancreatic ductal adenocarcinoma (PDA) |
+ |
MTOR | up-regulates
|
Proliferation |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255944 |
|
|
Homo sapiens |
|
pmid |
sentence |
20508131 |
The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255108 |
|
|
Homo sapiens |
|
pmid |
sentence |
15829723 |
Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K (47). This latter event has great potential importance for the promotion of muscle growth by the IGF-I/Akt/mTOR pathway, because p70S6k is a potent stimulator of protein synthesis that can be activated by increases in muscle contraction |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Tissue: |
HEK-293 Cell, Skeletal Muscle |
Pathways: | Acute Myeloid Leukemia, BCR-ABL in AML, FLT3 in AML, IDH-TET in AML, KIT in AML, miRNA in AML, FLT3-ITD in AML, FLT3-ITD signaling, Glioblastoma Multiforme, Leptin Signaling, Pancreatic ductal adenocarcinoma (PDA) |
+ |
PP121 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-206289 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
RAGAC | up-regulates activity
relocalization
|
MTOR |
0.804 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-228657 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
20381137 |
The Rag GTPases interact with mTORC1 and are proposed to activate it in response to amino acids by promoting mTORC1 translocation to a membrane-bound compartment that contains the mTORC1 activator, Rheb |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
1-[4-[[2-(2-amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)-6-thieno[3,2-d]pyrimidinyl]methyl]-1-piperazinyl]-2-hydroxy-1-propanone | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-192601 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CH5132799 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-190937 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
TM9SF4 | down-regulates activity
binding
|
MTOR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266703 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
29125601 |
TM9SF4 inhibited mTOR activity in HEK293 cells. Under nutrient starvation, TM9SF4 functions to facilitate mTOR inactivation, resulting in an enhanced autophagic flux, which serves to protect cells from apoptotic cell death. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
AZD-8055 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-190215 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
TSC1 | down-regulates activity
|
MTOR |
0.695 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-93130 |
|
|
Homo sapiens |
HEK-293 Cell, U2-OS Cell |
pmid |
sentence |
12271141 |
These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mtor. Here, we show that hamartin and tuberin function together to inhibit mammalian target of rapamycin (mtor)-mediated signaling to eukaryotic initiation factor 4e-binding protein 1 (4e-bp1) and ribosomal protein s6 kinase 1 (s6k1). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
AKT1 | up-regulates
phosphorylation
|
MTOR |
0.928 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255107 |
|
|
Homo sapiens |
|
pmid |
sentence |
15829723 |
Once phosphorylated, Akt can act on a broad spectrum of substrates that can influence cell survival and proliferation and protein synthesis (65). Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Skeletal Muscle |
Pathways: | FLT3-ITD signaling, Glioblastoma Multiforme, Parkinson |
+ |
phosphatidic acid | up-regulates
chemical activation
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-112379 |
|
|
Homo sapiens |
|
pmid |
sentence |
11729323 |
Pa directly interacted with the domain in mtor that is targeted by rapamycin, and this interaction was positively correlated with mtor's ability to activate downstream effectors. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTMR3 | down-regulates activity
|
MTOR |
0.361 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-245105 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
26787466 |
The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PI3K | up-regulates
|
MTOR |
0.562 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-252705 |
|
|
Homo sapiens |
|
pmid |
sentence |
18721898 |
Phosphoinositide 3-kinase (pi3k)-dependent activation of the rheb-mtor pathway triggers the simultaneous local synthesis of tc10 and par3. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, BCR-ABL in AML, FLT3 in AML, KIT in AML, FLT3-ITD in AML, FLT3-ITD signaling, Leptin Signaling, Pancreatic ductal adenocarcinoma (PDA) |
+ |
MTOR | form complex
binding
|
mTORC1 |
0.897 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-205615 |
|
|
Homo sapiens |
|
pmid |
sentence |
25628925 |
Depending on their binding partners and sensitivities to rapamycin, mtor resides in at least two distinct complexes, termed mtor complex 1 (mtorc1, containing raptor, fkbp12, pras40 and mlst8) and mtor complex 2 (mtorc2, containing rictor, sin1, protor and mlst8) |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Glioblastoma Multiforme, Pancreatic ductal adenocarcinoma (PDA) |
+ |
MTOR | up-regulates
|
Neurogenesis |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265771 |
|
|
|
|
pmid |
sentence |
29789464 |
The mTOR complexes are essential to neurogenesis and the establishment of neural circuits. | Activation of mTOR complexes exerts profound effects on all the processes of neurogenesis, including dendrite formation. |
|
Publications: |
1 |
Pathways: | Rett syndrome |
+ |
DEPTOR | down-regulates activity
binding
|
MTOR |
0.747 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251657 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
19446321 |
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | up-regulates
phosphorylation
|
GRB10 |
0.424 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-174071 |
|
|
Homo sapiens |
|
pmid |
sentence |
21659604 |
The adaptor protein grb10 was identified as an mtorc1 substrate that mediates the phosphoinositide 3-kinase. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, FLT3 in AML, FLT3-ITD signaling |
+ |
sirolimus | down-regulates activity
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-261074 |
|
|
Homo sapiens |
|
pmid |
sentence |
7566123 |
Consistent with an essential role for FRAP kinase activity in vivo, autophosphorylation of FRAP is inhibited by FKBP12-rapamycin. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling |
+ |
torkinib | down-regulates activity
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-258268 |
|
|
in vitro |
|
pmid |
sentence |
22037378 |
Our data set represents the most detailed comprehensive assessment of the reactivity of known and clinical kinase inhibitors across the kinome published to date. | The data also show that for at least 15 of the 27 kinases that are the primary, intended targets for the compounds tested and that are represented in the assay panel, selective inhibitors, as assessed by both absolute selectivity across the kinome and selectivity relative to the primary target, are among the 72 tested here. |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
1-[4-[1-(1,4-dioxaspiro[4.5]decan-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-pyrazolo[3,4-d]pyrimidinyl]phenyl]-3-methylurea | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-207800 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates
phosphorylation
|
ULK2 |
0.768 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-183961 |
|
|
Homo sapiens |
|
pmid |
sentence |
19211836 |
Mtor phosphorylates a mammalian homologue of atg13 and the mammalian atg1 homologues ulk1 and ulk2 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | up-regulates
|
Myotube_hypertrophy |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-191564 |
|
|
Homo sapiens |
|
pmid |
sentence |
22179044 |
In differentiated myofibres, we observed that wnt7a binding to fzd7 directly activates the akt/mtor growth pathway, thereby inducing myofibre hypertrophy. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Skeletal Muscle, Myotube |
+ |
torkinib | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-206313 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
torin 2 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-201499 |
|
|
Homo sapiens |
|
pmid |
sentence |
23436801 |
Torin2, a second generation atp-competitive inhibitor that is potent and selective for mtor.. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-207809 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PIK3CA | up-regulates
|
MTOR |
0.529 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-180453 |
|
|
Homo sapiens |
|
pmid |
sentence |
18721898 |
Phosphoinositide 3-kinase (pi3k)-dependent activation of the rheb-mtor pathway triggers the simultaneous local synthesis of tc10 and par3. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Glioblastoma Multiforme, MTOR Signaling |
+ |
MTOR | up-regulates
phosphorylation
|
EIF4EBP3 |
0.366 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-122035 |
|
|
Homo sapiens |
|
pmid |
sentence |
14967450 |
While promoting initiation of protein translation through mtor, eukaryoticinitiation factor 4e, and the ribosomal p70-s6 kinase. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
everolimus | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-167402 |
|
|
Homo sapiens |
Melanoma Cell |
pmid |
sentence |
20689758 |
M14, m288, and skmel28 (sensitive and resistant) were exposed to rad001, an mtor inhibitor, and to ly294002, a pi3k inhibitor. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
TSC | down-regulates activity
|
MTOR |
0.769 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-217907 |
|
|
Homo sapiens |
HEK-293 Cell, U2-OS Cell |
pmid |
sentence |
12271141 |
These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mtor |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
PKI-587 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-205986 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
GSK1059615 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-192693 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Temsirolimus | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-169712 |
|
|
Homo sapiens |
|
pmid |
sentence |
21081844 |
Temsirolimus, an inhibitor of mammalian target of rapamycin (mtor) complex 1, is approved for the treatment of metastatic renal cell carcinoma (rcc). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates
phosphorylation
|
EIF4EBP2 |
0.651 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-122014 |
|
|
Homo sapiens |
|
pmid |
sentence |
14967450 |
Here, we show that cancer cells acquire resistance to astori by downregulating eukaryotic translation initiation factor (eif4e)-binding proteins (4e-bps-eif4ebp1, eif4ebp2). |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-199258 |
|
|
Homo sapiens |
|
pmid |
sentence |
23100465 |
Here, we show that cancer cells acquire resistance to astori by downregulating eukaryotic translation initiation factor (eif4e)-binding proteins (4e-bps-eif4ebp1, eif4ebp2). |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
sirolimus | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-174886 |
|
|
Homo sapiens |
|
pmid |
sentence |
21757781 |
Rapamycin is an immunosuppressive drug that binds simultaneously to the 12-kda fk506- and rapamycin-binding protein (fkbp12, or fkbp) and the fkbp-rapamycin binding (frb) domain of the mammalian ta rget of rapamycin (mtor) kinase. autophagy is negatively regulated by the mammalian target of rapamycin (mtor) and can be induced in all mammalian cell types by the mtor inhibitor rapamycin. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-153608 |
|
|
Homo sapiens |
|
pmid |
sentence |
17350953 |
Rapamycin is an immunosuppressive drug that binds simultaneously to the 12-kda fk506- and rapamycin-binding protein (fkbp12, or fkbp) and the fkbp-rapamycin binding (frb) domain of the mammalian target of rapamycin (mtor) kinase. autophagy is negatively regulated by the mammalian target of rapamycin (mtor) and can be induced in all mammalian cell types by the mtor inhibitor rapamycin. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-179483 |
|
|
Homo sapiens |
|
pmid |
sentence |
18636076 |
Rapamycin is an immunosuppressive drug that binds simultaneously to the 12-kda fk506- and rapamycin-binding protein (fkbp12, or fkbp) and the fkbp-rapamycin binding (frb) domain of the mammalian target of rapamycin (mtor) kinase. autophagy is negatively regulated by the mammalian target of rapamycin (mtor) and can be induced in all mammalian cell types by the mtor inhibitor rapamycin. |
|
Publications: |
3 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling |
+ |
WYE-687 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-207818 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
AP 23573 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-166186 |
|
|
Homo sapiens |
|
pmid |
sentence |
20554235 |
Deforolimus was well tolerated on the schedule tested in this trial with toxicity and pharmacokinetic profiles that were similar to that of other mtor inhibitors. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle |
+ |
MTOR | up-regulates
phosphorylation
|
RPS6KB2 |
0.831 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-201541 |
|
|
Homo sapiens |
|
pmid |
sentence |
23486913 |
These results indicate that arg, leu, and gln act coordinately to stimulate proliferation of ptr cells through activation of the mtor-rps6k-rps6-eif4ebp1 signal transduction pathway. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-154821 |
|
|
Homo sapiens |
|
pmid |
sentence |
17510057 |
In response to insulin and nutrients, mtorc1, consisting of mtor, raptor (regulatory-associated protein of mtor), and mlst8, is activated and phosphorylates eukaryotic initiation factor 4e-binding protein (4ebp) and p70 s6 kinase to promote protein synthesis and cell size. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
WAY-600 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-207788 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
RAG1 | up-regulates
relocalization
|
MTOR |
0.259 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-198242 |
|
|
Homo sapiens |
|
pmid |
sentence |
22790199 |
Rag gtpases, together with a multi-protein complex called ragulator, mediate amino acid-mediated mtor recruitment to the lysosome surface where mtor becomes activated. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
TSC2 | down-regulates activity
|
MTOR |
0.844 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-93133 |
|
|
Homo sapiens |
HEK-293 Cell, U2-OS Cell |
pmid |
sentence |
12271141 |
These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mtor |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | form complex
binding
|
mTORC2 |
0.727 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-262534 |
|
|
Homo sapiens |
|
pmid |
sentence |
25628925 |
Depending on their binding partners and sensitivities to rapamycin, mtor resides in at least two distinct complexes, termed mtor complex 1 (mtorc1, containing raptor, fkbp12, pras40 and mlst8) and mtor complex 2 (mtorc2, containing rictor, sin1, protor and mlst8) |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | FLT3-ITD signaling, MTOR Signaling |
+ |
FKBP8 | down-regulates
binding
|
MTOR |
0.582 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-159013 |
|
|
Homo sapiens |
|
pmid |
sentence |
17991864 |
Fkbp38 binds to mtor and inhibits its activity in a manner similar to that of the fkbp12-rapamycin complex. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
MTOR | down-regulates
phosphorylation
|
ATG13 |
0.638 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-183965 |
|
|
Homo sapiens |
|
pmid |
sentence |
19211837 |
Mtor phosphorylates a mammalian homologue of atg13 and the mammalian atg1 homologues ulk1 and ulk2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
AKT2 | up-regulates
|
MTOR |
0.625 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-101324 |
|
|
Homo sapiens |
|
pmid |
sentence |
12782654 |
It was shown recently that akt activates mtor through direct phosphorylation of tsc2 the serine/threonine kinase akt is an upstream positive regulator of the mammalian target of rapamycin (mtor). However, the mechanism by which akt activates mtor is not fully understood. The known pathway by which akt activates mtor is via direct phosphorylation and tuberous sclerosis complex 2 (tsc2), which is a negative regulator of mtor. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Skeletal Muscle |
+ |
RHEB | up-regulates activity
binding
|
MTOR |
0.949 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-135770 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
15854902 |
Rheb binds and regulates the mTOR kinase. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-162006 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
20006481 |
Rheb stimulates the phosphorylation of mtor and plays an essential role in regulation of s6k and 4ebp1 in response to nutrients and cellular energy status. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | MTOR Signaling |
+ |
Ku-0063794 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-168188 |
|
|
Homo sapiens |
|
pmid |
sentence |
20884880 |
Sgk-1 activation in response to stretch is blocked by insulin-like growth factor (igf)-1 receptor inhibitor and mammalian target of rapamycin complex (mtorc)2 inhibitor (ku-0063794) but not mtorc1 inhibitor (rapamycin). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Smooth Muscle |
+ |
miR-199a | up-regulates activity
|
MTOR |
0.4 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255803 |
|
|
Homo sapiens |
|
pmid |
sentence |
26055960 |
Our results suggest that activating mutation of FLT3 in AML can lead, to increased expression of miR-155, which then causes down-regulation of SPI1 and CEBPB and consequently causes block of myeloid differentiation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, miRNA in AML |
+ |
DUSP16 | down-regulates activity
dephosphorylation
|
MTOR |
0.278 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277067 |
|
|
Homo sapiens |
|
pmid |
sentence |
25077541 |
MKP7 represses mTOR function.|These results suggest that MKP7 could directly dephosphorylate pmTOR and pPRAS40 and forming complexes with these two proteins ( xref ). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
RAG2 | up-regulates
relocalization
|
MTOR |
0.271 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-198245 |
|
|
Homo sapiens |
|
pmid |
sentence |
22790199 |
Rag gtpases, together with a multi-protein complex called ragulator, mediate amino acid-mediated mtor recruitment to the lysosome surface where mtor becomes activated. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Palomid 529 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-199120 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
XL765 | down-regulates
chemical inhibition
|
MTOR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-207869 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
AMPK | down-regulates activity
|
MTOR |
0.549 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-260096 |
|
|
Homo sapiens |
|
pmid |
sentence |
30274374 |
AMPK inhibits the mTOR pathway through phosphorylation and activation of tuberous sclerosis protein 2 (TSC2) and causes direct activation of unc-51-like autophagy activating kinase 1 (ULK1) via phosphorylation of Ser555, thus promoting initiation of autophagy. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Acute Myeloid Leukemia, IDH-TET in AML, FLT3-ITD signaling, Leptin Signaling, MTOR Signaling |
+ |
GOLPH3 | up-regulates activity
|
MTOR |
0.338 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-253554 |
|
|
Homo sapiens |
A-549 Cell, 1205-Lu Cell |
pmid |
sentence |
19553991 |
Mechanistically, GOLPH3 regulates cell size, enhances growth factor-induced mTOR signaling in human cancer cells and alters response to mTOR inhibitor in vivo. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
ABL1 | down-regulates
phosphorylation
|
MTOR |
0.465 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-76562 |
|
|
Homo sapiens |
|
pmid |
sentence |
10753870 |
Abl binds directly to raft1 and phosphorylates raft1 in vitro and in vivo. c-abl inhibits autophosphorylation of raft1 and raft1-mediated phosphorylation p70(s6k). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |